Literature DB >> 8587796

Ex vivo evidence for PGE2 and LTB4 involvement in cutaneous leishmaniasis: relation with infection status and cytokine production.

S Milano1, F Arcoleo, M Dieli, R D'Agostino, G De Nucci, P D'Agostino, E Cillari.   

Abstract

Ex vivo culture of spleen cells from BALB/c mice infected with 2 x 10(6) Leishmania major (L. major) promastigotes were cultured with ConcanavalinA (ConA) or leishmanial antigen (L. Ag) and tested for prostaglandin E2 (PGE2) and for leukotriene B4 (LTB4), in order to study their involvement in the evolution of cutaneous leishmaniasis and the connexion with lymphokine-mediated responses. The data were compared with those obtained in BALB/c mice protected against L. major by sublethal irradiation (550 rad; cured mice). In the unprotected BALB/c mice the levels of PGE2 that were responsible for the depression of interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF alpha) Th1-associated cytokines and for the relative increase in the interleukin-4 (IL-4) became higher and higher as the lesion progressed. On the contrary, the cured mice produced levels of PGE2 similar to normal uninfected controls, high levels of TNF alpha and IFN-gamma and low levels of IL-4. Elevated levels of LTB4 were detected in the early stage of infection in the unprotected mice compared to cured ones, a sign of more intense inflammation and a stimulus for the recruitment of inflammatory cells. The observation that exogenous LTB4 was able to enhance in vitro both Th1 cytokines in cured mice and Th2 cytokines in unprotected ones suggests that LTB4 could act in the recruitment of the T cells already committed to Th1 or Th2 phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8587796     DOI: 10.1017/s0031182000065033

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  9 in total

1.  Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

Authors:  V Yardley; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

2.  An in vitro model for infection with Leishmania major that mimics the immune response in mice.

Authors:  M B Soares; J R David; R G Titus
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  The p47(phox-/-) mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs.

Authors:  B H Segal; T M Doherty; T A Wynn; A W Cheever; A Sher; S M Holland
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection.

Authors:  M V Lonardoni; M Russo; S Jancar
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 5.  Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).

Authors:  Pio Conti; Alessandro Caraffa; Gianpaolo Ronconi; Chiara M Conti; Spiros K Kritas; Filiberto Mastrangelo; Lucia Tettamanti; Theoharis C Theoharides
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

6.  Protective immunity and vaccination against cutaneous leishmaniasis.

Authors:  Ifeoma Okwor; Zhirong Mou; Dong Liu; Jude Uzonna
Journal:  Front Immunol       Date:  2012-05-29       Impact factor: 7.561

7.  Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells.

Authors:  Véronique Provost; Anick Langlois; François Chouinard; Marek Rola-Pleszczynski; Jamila Chakir; Nicolas Flamand; Michel Laviolette
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

Review 8.  Role of leukotrienes on protozoan and helminth infections.

Authors:  Alexandre P Rogerio; Fernanda F Anibal
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

Review 9.  Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control.

Authors:  Rodrigo A López-Muñoz; Alfredo Molina-Berríos; Carolina Campos-Estrada; Patricio Abarca-Sanhueza; Luis Urrutia-Llancaqueo; Miguel Peña-Espinoza; Juan D Maya
Journal:  Front Microbiol       Date:  2018-08-21       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.